At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
High flow nasal cannula +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Physiological Changes With High-Flow Nasal Cannula Compared to Nasal CPAP in Extremely Low Birth Weight Infants
In Brief
A clinical study evaluating High flow nasal cannula and Nasal CPAP for Respiratory Distress Syndrome in Premature Infant. Completed, enrolled 80 participants across 1 site.
Detailed Summary
To measure changes in physiologic parameters in extremely low birthweight (ELBW) infants on high-flow nasal cannula compared to nasal continuous positive airway pressure (nCPAP).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 2018
Enrollment StartMar 2019
Primary CompletionDec 2021
Study CompletionFeb 2022
TodayJul 2026
First PostedOct 9, 2018
Enrollment StartMar 15, 2019
Primary CompletionDec 20, 2021
Study CompletionFeb 14, 2022
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 7.7 years ago
Interventions
High flow nasal cannulaprocedure
8 liters per minute of blended oxygen through Fisher Paykel Optiflow Jr 2 nasal prongs.
Nasal CPAPprocedure
Nasal continuous positive airway pressure of 5-7 cm/H20 delivered using Ventilator or bubble cpap device through short nasal prongs or a nasal face mask.